Spectrum and risk factors of invasive fungal infection

In recent years, invasive fungal infection has become a growing problem in immunosuppressed patients. Simultaneously, changes in medical practice, such as the use of anti-Candida prophylaxis with azoles, has led to a shift in the epidemiology of these infections from Candida spp. to Aspergillus and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Enfermedades infecciosas y microbiología clínica 2007-08, Vol.25 (7), p.467
Hauptverfasser:	Osorio, Juan José Castón, Román, Antonio Rivero, Torre-Cisneros, Julián
Format:	Artikel
Sprache:	spa
Schlagworte:	Adult Antifungal Agents - administration & dosage Antifungal Agents - therapeutic use Antineoplastic Agents - adverse effects Aspergillosis - drug therapy Aspergillosis - epidemiology Child Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - microbiology Female Fungemia - drug therapy Fungemia - epidemiology Fungemia - prevention & control Humans Immunocompromised Host Immunosuppressive Agents - adverse effects Immunosuppressive Agents - classification Infant Male Mycoses - drug therapy Mycoses - epidemiology Mycoses - prevention & control Neutropenia - chemically induced Neutropenia - complications Risk Factors Spain - epidemiology Zygomycosis - drug therapy Zygomycosis - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!